Inhibiting Phosphorylation of Tau (τ) Proteins at Ser262 Using Peptide-Based R1 Domain Mimetics
Authors:
- 8 March 2018
- journal article
- research article
- Published by Springer Nature in International Journal of Peptide Research and Therapeutics
- Vol. 25 (2) , 447-463
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Selective kinase inhibitors as tools for neuroscience researchNeuropharmacology, 2012
- Cdk5: a multifaceted kinase in neurodegenerative diseasesTrends in Cell Biology, 2012
- Microtubule Affinity Regulating Kinase Activity in Living Neurons Was Examined by a Genetically Encoded Fluorescence Resonance Energy Transfer/Fluorescence Lifetime Imaging-based BiosensorJournal of Biological Chemistry, 2011
- Phosphorylation of Tau at Thr212, Thr231, and Ser262 Combined Causes NeurodegenerationJournal of Biological Chemistry, 2010
- Effects of endocytosis inhibitors on internalization of human IgG by Caco-2 human intestinal epithelial cellsLife Sciences, 2009
- Mechanism of Neuronal versus Endothelial Cell Uptake of Alzheimer's Disease Amyloid β ProteinPLOS ONE, 2009
- Structure and regulation of MARK, a kinase involved in abnormal phosphorylation of Tau proteinBMC Neuroscience, 2008
- The Par-1/MARK Family of Protein Kinases: From Polarity to MetabolismCell Cycle, 2007
- Endosome disruption enhances the functional nuclear delivery of Tat-fusion proteinsBiochemical and Biophysical Research Communications, 2004
- Protein Kinase MARK/PAR-1 Is Required for Neurite Outgrowth and Establishment of Neuronal PolarityMolecular Biology of the Cell, 2002